| Similar Articles |
|---|
 |
The Motley Fool
March 31, 2010
Brian Orelli |
When One Patent Means So Much The loss of patents on genes could have far-reaching consequences for drug companies.   |
The Motley Fool
February 2, 2010
Brian Orelli |
Shaking Up the Biotech Industry A judge will decide if genes are patentable or not. |
Bio-IT World
November 12, 2002
Andrew W. Torrance |
After the Gene Rush About 20,000 gene-related patents have been granted in the U.S. so far, with twice as many on the way. The practical and political challenges are equally large. |
Bio-IT World
November 12, 2002
Sue Mayer |
Are Gene Patents in the Public Interest? Two recent studies from Britain argue against the unbridled patenting of genes and raise tough ethical questions. |
Bio-IT World
November 12, 2002
Paula Campbell Evans |
Patently More Difficult The PTO has targeted gene patents with new application guidelines. Here's what they mean and how biotech companies can satisfy them. |
The Motley Fool
July 1, 2011
Dan Radovsky |
Can the Human Genetics Industry Survive the Courts? The future of gene patents is at stake. |
Salon.com
May 1, 2000
Arthur Allen |
Listening to DNA The genome project is getting the buzz. But the real breakthroughs may come from labs out of the limelight, like Gene Logic. |
Bio-IT World
August 13, 2003
Kevin Davies |
Playing by Aussie Rules GTG's Mervyn Jacobson discusses the controversial patenting of non-coding DNA. |
Bio-IT World
November 12, 2002
Davies et al. |
John Craig Venter Unvarnished The former Celera CEO talks about that company's politics, the future of sequencing technology, and his own genome. |
Bio-IT World
August 13, 2003
Kevin Davies |
Malcolm in the Middle A maverick scientist and entrepreneur finds himself at the center of a DNA patenting storm. |
Bio-IT World
October 9, 2002
Kevin Davies |
Cracking the 'Druggable Genome' How many potential drug targets are encoded in the human genome? It is a crucial question for every biopharma business. |
ONLINE
Nov/Dec 2008
Suzanne Sabroski |
From Concept to Content: The Genesis of USGENE Last year a groundbreaking database known as USGENE was released on STN International, a service of FIZ Karlsruhe and Chemical Abstracts Service (CAS). USGENE allows searchers to perform freedom-to-operate, prior art, validity, and infringement patent sequence searches. |
Bio-IT World
November 12, 2002
Beth E. Arnold |
Navigating Gene Patent Minefields As the number of gene-related patents soars, so do the chances of patent infringement. Here are tips to avoid a costly misstep in this legal minefield. |
Wired
June 2000
Brian Alexander |
Biopoly Money Patents and strong-arm tactics are helping make Affymetrix the Intel of biochips. Along the way, Affy wants to turn DNA into a proprietary system. |
Inc.
July 24, 2002
Jennifer A. Redmond |
Strategic Patenting What to consider when you're filing a patent and strategic decisions you'll need to make. |
Bio-IT World
November 19, 2004
Lentini & Bent |
Intellectual Property: Patents and Genomic Medicine Patents, so critical to encouraging investment in developing new technologies, threaten to become a legal and economic minefield that could prevent effective commercial exploitation of genomics. |
Salon.com
June 27, 2000
Tabitha M. Powledge |
Book of life? Hosanna! The Human Genome Project has been completed. We will now cure diseases, weed out defective genes and create a new supergeneration in the near future. Not. |
Entrepreneur
October 2005
Chris Penttila |
Patent Pending Have an idea for the next big thing? You'll need a patent, but pay attention to big changes in store for U.S. patent law. |
Fast Company
November 2009
David H. Freedman |
The Gene Bubble: Why We Still Aren't Disease-Free When the human genome was first sequenced nearly a decade ago, the world lit up with talk about how new gene-specific drugs would help us cheat death. Well, the verdict is in: Keep eating those greens. |
Wired
August 2000
Jennifer Hillner |
Area 22 The inside story of the first fully sequenced chromosome. |
InternetNews
May 20, 2005
Sean Michael Kerner |
A Primer on Software Patents A closer look at software patents and at their history and implications for IT. |
Chemistry World
June 20, 2013
Sarah Houlton |
US supreme court rules genes can't be patented In a long-running case against Myriad Genetics, the court decided the BRCA1 and BRCA2 genes are a 'product of nature, and not patent eligible merely because [they have] been isolated.' |
The Motley Fool
April 26, 2005
Dave Mock |
The Lowdown on Patent Shakedowns The business of extorting license fees for patents can be very lucrative -- and damaging. It is important for investors to understand how the companies they own utilize and protect their inventions -- and what approach management has taken to deal with intellectual property disputes. |
Pharmaceutical Executive
September 1, 2010 |
Looking Beyond the Patent Cliff Pfizer's VP and Assistant General Counsel for Global Patents and Policy, Roy Waldron, discusses its collaborative strategy to refresh the face of IP. |
Reason
Aug/Sep 2000
Ronald Bailey |
Strands of Life Book Review: Genome: The Autobiography of a Species in 23 Chapters, by Matt Ridley |
Pharmaceutical Executive
May 1, 2005
Margaret Buck |
Legal: No Exception? An important legal loophole has made patented tools available for biotech research. Today, though, it appears to be closing. |
Bio-IT World
March 8, 2005
Kevin Davies |
Evolution of New Genes Studied EMBL researchers use comparative genomic analysis to identify new primate-specific gene family. |
Pharmaceutical Executive
August 1, 2005
Jill Wechsler |
Washington Report: Treating Patents It may seem unusual that a court ruling challenging patent protections is considered a victory for Big Pharma. But the decision was supported by pharmaceutical companies, along with the Justice Department, as a way to spur biomedical research and new-drug development. |
Linux Journal
May 1, 2002
Lawrence Rosen |
The Role of Standards in Open Source And, on how new standards are often compatible with free and open-source licensing... |
Bio-IT World
November 2005
Khaleeli & Fernandez |
Patent Prosecution and Enforcement in Pharmacogenomics Patenting the composition of an isolated nucleic acid sequence, an isolated protein, and small molecules is possible, but there are challenges claiming that they resulted from pharmacogenomic research. |
BusinessWeek
June 13, 2005
John Carey |
The NIH's Roadmap for Research Charting the human genome was just the beginning. Now the focus is creating pathways that will lead to practical applications. |
Bio-IT World
April 15, 2003
Malorye Branca |
Beyond the Blueprint How will the wealth of data emanating from the human genome and allied technologies impact research on health and disease? |
IndustryWeek
October 1, 2007
Jill Jusko |
Patent Protection Your valuable intellectual property requires keen oversight. To help keep it safe, consider these actions. |
| Knowledge@Wharton |
Why High-Tech Firms Can't Afford to Ignore Patents When it comes to patents, high technology firms are, out of necessity, interdependent... |
Bio-IT World
December 15, 2003
Kline & Greenhalgh |
When Patents Persist What if that patent you're paying royalties on suddenly gets extended? Have you negotiated the best licensing deal possible? |
Information Today
August 4, 2011 |
Elsevier Introduces Genome Viewer The Genome Viewer is a SciVerse application that displays detailed gene or genomic sequence information on the genes mentioned in an article. |
Bio-IT World
June 17, 2004
Cathryn Campbell |
Patent Plaintiff Perils Suing for patent infringement may seem rewarding, but you could lose even more. |
Salon.com
February 26, 2002
Annalee Newitz |
Genome liberation The information that details who we are is too important to be privately owned... |
Wall Street & Technology
September 19, 2006
Paul Allen |
Patent Processing For both the patent holders and potential transgressors, technology patents can be a high-stakes game in the financial world, in both monetary awards and ongoing business feasibility. |
Wired
June 2000
Evan Ratliff |
Patent Upending The invention police can't stand Greg Aharonian, who says the fuss over Amazon's "one-click" plan is old news. The real problem: The government lost its grip on intellectual property long ago.... |
CIO
August 1, 2003
Lawrence Rosen |
Patents: An Expensive Tax on the CIO Software patents cost you money. Like taxes, they skim from your profit margins, but in this case the fees go to pay for other companies' intellectual property. |
CIO
January 1, 2003
Christopher Koch |
Patently Stupid? It's not clear at the start of 2003 whether the software patent frenzy will cause innovation to flower or be trampled. |
InternetNews
June 11, 2004
Susan Kuchinskas |
Microsoft Patent in Review The United States Patent and Trademark Office granted a request by the Public Patent Foundation to review one of Microsoft's many patents, the organization said today. |
InternetNews
June 4, 2004
Susan Kuchinskas |
Microsoft Double-click Patent Sows FUD Will you pay Redmond every time you click-click? |
Salon.com
March 21, 2001
Damien Cave |
Patents are your friends Can open-source programmers use intellectual property laws to protect themselves from corporate software snatchers? Publishing work on IP.com ensures the patent office will see it and not issue patent for the idea to someone else. |
CIO
August 1, 2003
Mark Radcliffe |
Patents: A Small Price to Pay for Progress For CIOs, the issue is not whether patents should be granted for software but whether anything can be done to improve the quality of the granted patents. The problem relates more to the examining process in the USPTO than to the appropriateness of patents for software. |
Bio-IT World
November 2005
Patrick R. Scanlon |
Patent Term Extension Primer U.S. patent law includes provisions for extending the patent term of medical devices and pharmaceuticals in instances when lengthy FDA approval is taking place during the term. |
BusinessWeek
May 9, 2005 |
A Genome Pioneer Looks Forward Dr. Francis Collins discusses the end of the Human Genome Project and says an "outpouring of discoveries" is coming soon. |
IndustryWeek
August 1, 2006 |
Patents: Eleven Issues To Consider... How patent savvy are you? |
The Motley Fool
September 28, 2006
Jack Uldrich |
IBM's Patently Good Idea Big Blue's decision to open patents to public scrutiny could spur innovation. |
